Cargando…

Kidney failure of unknown cause: a call to admit our uncertainty

Detalles Bibliográficos
Autor principal:	Böhlke, Maristela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Nefrologia 2023
Materias:	Letter And Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697156/ https://www.ncbi.nlm.nih.gov/pubmed/37229776 http://dx.doi.org/10.1590/2175-8239-JBN-2022-0134en

Ejemplares similares

This Strange Being Called the Cosmos
por: Hui, Yuk
Publicado: (2021)

Gender Inequities in the Multiple Sclerosis Community: A Call for Action
Publicado: (2018)

An unusual cause of new-onset ascites and apparent severe acute kidney injury
por: Oliveira, João, et al.
Publicado: (2022)

Commentary on: A call for better reporting of trials using surrogate primary endpoints
por: Cummings, Jeffrey
Publicado: (2022)

Reply to “Comment on Fitria et al. ‘Environmental and Occupational Risk Factors Associated with Chronic Kidney Disease of Unknown Etiology in West Javanese Rice Farmers, Indonesia’ Int. J. Environ. Res. Public Health, 2020, 17, 4521”
por: Fitria, Laila, et al.
Publicado: (2020)

COVID-19-induced acute kidney injury and chronic kidney disease: comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

The association between acute kidney injury in renal infarction and progression to chronic kidney disease
por: Oh, Yun Kyu
Publicado: (2016)

COVID-19-induced acute kidney injury and chronic kidney disease: correspondence response
por: Musso, Carlos G., et al.
Publicado: (2022)

Modelling in the light of uncertainty of key parameters: a call to exercise caution in field predictions of Bt-maize effects
por: Lang, A., et al.
Publicado: (2011)

Reply to letters regarding our paper “Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Societyˮ
por: Kapoor, Aditya, et al.
Publicado: (2020)

Pulmonary hypertension in chronic kidney disease: what could change the fate?
por: Lee, Soo Bong
Publicado: (2016)

Is there an association between quadriceps thickness and functional capacity in patients with chronic kidney disease?
por: de Paula, Bruno Lionardo, et al.
Publicado: (2022)

Reply to: A genomic cause of cerebral palsy should not change the clinical classification
por: Takezawa, Yusuke, et al.
Publicado: (2018)

Three Doses of Hepatitis B Vaccine or Four Doses in Chronic Renal Failure
por: Khazaeipour, Zahra, et al.
Publicado: (2013)

Sodium‐glucose transporter 2 inhibitors may improve the prognosis of acute heart failure by correcting hypocapnia
por: Tang, Wen‐Jing, et al.
Publicado: (2023)

Toll-like receptor 4 antagonist and obesity associated kidney disease: Where should we go from here?
Publicado: (2015)

Response to Letter to the editor regarding ‘Discordance between estimated and measured changes in plasma volume among patients with acute heart failure’
por: Swolinsky, Jutta S., et al.
Publicado: (2022)

Reply to Comments by Yih et al. (Exposure to Hantavirus is a Risk Factor Associated with Kidney Diseases in Sri Lanka: A Cross-Sectional Study)
por: Sarathkumara, Yomani D., et al.
Publicado: (2019)

Reply to: Adult‐onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?
por: Lee, Yi‐Chung, et al.
Publicado: (2022)

Response to Latest British Society of Echocardiography recommendations for left ventricular ejection fraction categorisation: potential implications and relevance to contemporary heart failure management
por: Harkness, Allan, et al.
Publicado: (2020)

Comment on “Renail failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice” by Kawao et al. ‐ the authors' reply
por: Kawao, Naoyuki, et al.
Publicado: (2022)

Reply to Comments: Comparison of Methods Study between a Photonic Crystal Biosensor and Certified ELISA to Measure Biomarkers of Iron Deficiency in Chronic Kidney Disease Patients
por: Peterson, Ross D., et al.
Publicado: (2020)

Reply to Li, A.-H.; Chiu, Y.-L. Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on “Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. J. Clin. Med. 2022, 11, 5612”
por: Chen, Yi-Chun, et al.
Publicado: (2022)

Study on the Postoperative Pain Calls for More Methods to Control Potential Bias
por: Guo, Wei, et al.
Publicado: (2016)

mtDNA Mutation Accumulation in Muscle Is Not a Major Cause of Fiber Loss. Reply to “Comment on: Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging. Cells 2020, 9, 197”
por: Hepple, Russell T.
Publicado: (2020)

Reply to Janssen et al. Comment on “Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069”
por: Kremer, Daan, et al.
Publicado: (2022)

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
por: Boelaert, Jente, et al.
Publicado: (2016)

At the Right Place, at the Right Time. Reply to Vetrugno et al. Comparison between FlowTrac and Pulmonary Arterial Catheter in Off-Pump Cardiac Surgery Patients: “Why Did We Miss Our Appointment?”. Comment on “Oh et al. Comparison between Fourth-Generation FloTrac/Vigileo System and Continuous Thermodilution Technique for Cardiac Output Estimation after Time Adjustment during Off-Pump Coronary Artery Bypass Graft Surgery: A Retrospective Cohort Study. J. Clin. Med. 2022, 11, 6093”
por: Oh, Chahyun, et al.
Publicado: (2023)

Reply to Argüelles and Argüelles-Prieto, “Are the Editors Responsible for Our Obsession with the Impact Factor?”
por: Casadevall, Arturo, et al.
Publicado: (2017)

Response to Ahlbom et al. Comments on Hardell and Carlberg Increasing Rates of Brian Tumors in the Swedish National Inpatient Register and the Causes of Death Register. Int. J. Environ. Res. Public Health 2015, 12, 3793–3813
por: Hardell, Lennart, et al.
Publicado: (2015)

Reply to Pavlik et al. Clinical Relevance and Environmental Prevalence of Mycobacterium fortuitum Group Members. Comment on “Mugetti et al. Gene Sequencing and Phylogenetic Analysis: Powerful Tools for an Improved Diagnosis of Fish Mycobacteriosis Caused by Mycobacterium fortuitum Group Members. Microorganisms 2021, 9, 797”
por: Mugetti, Davide, et al.
Publicado: (2021)

Is the Reluctance for the Implantation of Right Kidneys Justified: Reply
por: Özdemir-van Brunschot, Denise M. D., et al.
Publicado: (2016)

Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
por: Bocchi, Edimar Alcides, et al.
Publicado: (2018)

A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report
por: Smyth, Michael D. L., et al.
Publicado: (2009)

Sulodexide in IgA nephropathy
Publicado: (2013)

Wunderlich syndrome in a patient on hemodialysis
por: Roxo, Maria Inês, et al.
Publicado: (2023)

Letter in Reply: A Case of the Great Imitator
por: Al-Riyami, Hana Ali, et al.
Publicado: (2020)

Reply to: A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation
por: Coffman, Abigail A, et al.
Publicado: (2021)

A new water channel aquaporin-11: extension to renal transplantation
Publicado: (2015)

IgA nephropathy combined with thin basement membrane nephropathy in children
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mchgld6a9bejtneb6k2b3sklt0